Polyrizon Ltd. (PLRZ)
NASDAQ: PLRZ · Real-Time Price · USD
0.945
-0.035 (-3.57%)
At close: Nov 20, 2024, 4:00 PM
0.950
+0.005 (0.53%)
After-hours: Nov 20, 2024, 4:04 PM EST
Company Description
Polyrizon Ltd., a biotech company, engages in the development of medical device hydrogels in the form of nasal sprays in Israel.
The company uses its proprietary technology to develop its products comprising Capture and Contain, a containment barrier against a range of allergen particulates and viruses; and Trap and Target for nasal delivery of active pharmaceutical ingredients.
It develops PL-14, a nasal allergies blocker; PL-15 for COVID-19; and PL-16 for influenza. The company was incorporated in 2005 is headquartered in Ra'anana, Israel.
Polyrizon Ltd.
| Country | Israel |
| Founded | 2005 |
| IPO Date | Oct 29, 2024 |
| Industry | Health Care |
| Sector | Biotechnology |
| Employees | 3 |
| CEO | Tomer Izraeli |
Contact Details
Address: 5 Ha-Tidhar Street Ra'anana, 4366507 Israel | |
| Phone | 972 5 5433 5665 |
| Website | polyrizon-biotech.com |
Stock Details
| Ticker Symbol | PLRZ |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $4.38 |
| CIK Code | 0001893645 |
| ISIN Number | IL0011814113 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Tomer Izraeli | Chief Executive Officer, Director |
| Nir Ben Yosef | Chief Financial Officer |
| Dr. Eyal S. Ron | Chief Technology Officer |
| Dr. Tidhar Turgeman | Chief R&D Officer |
| Daphna Avital | Chief People Officer |
| Dr. Roy Borochov | Director |
| Liron Carmel | Director |
| Oz Adler | Director |
| Raul Srugo | Director |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Oct 30, 2024 | 6-K | Report of foreign issuer |
| Oct 30, 2024 | 424B4 | Prospectus |
| Oct 30, 2024 | 424B4 | Prospectus |
| Oct 28, 2024 | EFFECT | Notice of Effectiveness |
| Oct 28, 2024 | CERT | Certification by an exchange approving securities for listing |
| Oct 21, 2024 | 8-A12B | Registration of securities |
| Oct 2, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 25, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 23, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 16, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |